Garda Capital Partners LP Biogen Inc. Transaction History

Garda Capital Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $38,587 - $48,723	-182 Reduced 10.34%	1,579 $340,000
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $214,799 - $258,562	965 Added 121.23%	1,761 $455,000
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $201,626 - $227,568	796 New	796 $204,000
Q1 2023 May 10, 2023	BUY	$256.56 - $292.34 $47,720 - $54,375	186 New	186 $51,000

1,049

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $26.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Garda Capital Partners LP, based on Form 13F filings with the SEC.

Stay updated on Garda Capital Partners LP with notifications on news.